WESTON, Fla., Aug. 26 /PRNewswire-FirstCall/ -- American Scientific Resources, Inc. (the Company), today confirmed that it has signed a letter of intent to acquire the intellectual property to the Disintegrator home needle destruction device (NDD) (U.S. Patent No. 6,384,362 Patent Application No.: 09/500,504).
Currently the only FDA approved NDD for home use, the Disintegrator enables patients who give themselves injections, including those suffering from multiple sclerosis or diabetes, to properly and safely dispose of needles at home. The device is approved by the EPA and the American Diabetes Association.
A congressional bill (S, 1312) is pending which would amend Title XVIII of the Social Security Act to provide for coverage, as supplies associated with the injection of insulin, of containment, removal, decontamination, and disposal of home-generated needles, syringes, and other sharps through a sharps decontamination/destruction device or similar program under part D of the Medicare program.
More information about the Company, including financial information, can be found on the ASFX web site at www.americansci.com. For product information, visit the Company's subsidiary, Kidz-Med, Inc. at www.kidzmed.com.
American Scientific Resources, Inc.
